Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 1713 | 2442 | 39.4 | 80% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 77 | 26633 | NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//NUCLEOSIDES & NUCLEOTIDES//NUCLEOSIDES |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT | Journal | 54 | 34% | 5% | 128 |
| 2 | ANTISENSE RESEARCH AND DEVELOPMENT | Journal | 38 | 60% | 2% | 42 |
| 3 | ANTISENSE | Author keyword | 26 | 11% | 9% | 229 |
| 4 | PHOSPHOROTHIOATE | Author keyword | 23 | 31% | 3% | 63 |
| 5 | ANTISENSE OLIGONUCLEOTIDES | Author keyword | 21 | 15% | 5% | 126 |
| 6 | OLIGONUCLEOTIDE | Author keyword | 11 | 10% | 4% | 107 |
| 7 | ANTISENSE OLIGONUCLEOTIDE | Author keyword | 9 | 11% | 3% | 77 |
| 8 | ANTISENSE IMAGING | Author keyword | 6 | 80% | 0% | 4 |
| 9 | PHOSPHOROTHIOATE OLIGONUCLEOTIDE | Author keyword | 6 | 45% | 0% | 10 |
| 10 | OLIGODEOXYNUCLEOTIDES | Author keyword | 5 | 16% | 1% | 30 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ANTISENSE | 26 | 11% | 9% | 229 | Search ANTISENSE | Search ANTISENSE |
| 2 | PHOSPHOROTHIOATE | 23 | 31% | 3% | 63 | Search PHOSPHOROTHIOATE | Search PHOSPHOROTHIOATE |
| 3 | ANTISENSE OLIGONUCLEOTIDES | 21 | 15% | 5% | 126 | Search ANTISENSE+OLIGONUCLEOTIDES | Search ANTISENSE+OLIGONUCLEOTIDES |
| 4 | OLIGONUCLEOTIDE | 11 | 10% | 4% | 107 | Search OLIGONUCLEOTIDE | Search OLIGONUCLEOTIDE |
| 5 | ANTISENSE OLIGONUCLEOTIDE | 9 | 11% | 3% | 77 | Search ANTISENSE+OLIGONUCLEOTIDE | Search ANTISENSE+OLIGONUCLEOTIDE |
| 6 | ANTISENSE IMAGING | 6 | 80% | 0% | 4 | Search ANTISENSE+IMAGING | Search ANTISENSE+IMAGING |
| 7 | PHOSPHOROTHIOATE OLIGONUCLEOTIDE | 6 | 45% | 0% | 10 | Search PHOSPHOROTHIOATE+OLIGONUCLEOTIDE | Search PHOSPHOROTHIOATE+OLIGONUCLEOTIDE |
| 8 | OLIGODEOXYNUCLEOTIDES | 5 | 16% | 1% | 30 | Search OLIGODEOXYNUCLEOTIDES | Search OLIGODEOXYNUCLEOTIDES |
| 9 | ANTISENSE OLIGODEOXYNUCLEOTIDES | 5 | 15% | 1% | 29 | Search ANTISENSE+OLIGODEOXYNUCLEOTIDES | Search ANTISENSE+OLIGODEOXYNUCLEOTIDES |
| 10 | EXONUCLEASE RESISTANCE | 4 | 67% | 0% | 4 | Search EXONUCLEASE+RESISTANCE | Search EXONUCLEASE+RESISTANCE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | OLIGODEOXYNUCLEOTIDES | 95 | 19% | 19% | 462 |
| 2 | PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES | 88 | 41% | 7% | 165 |
| 3 | OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES | 56 | 76% | 2% | 39 |
| 4 | ANTISENSE OLIGONUCLEOTIDES | 43 | 12% | 14% | 348 |
| 5 | PHOSPHOROTHIOATE OLIGONUCLEOTIDES | 38 | 34% | 4% | 93 |
| 6 | C 14 LABELED PHOSPHOROTHIOATE OLIGONUCLEOTIDE | 37 | 73% | 1% | 29 |
| 7 | CHRONICALLY INFECTED CELLS | 37 | 57% | 2% | 44 |
| 8 | PHOSPHOROTHIOATE OLIGONUCLEOTIDE | 37 | 48% | 2% | 56 |
| 9 | C ALPHA EXPRESSION | 26 | 58% | 1% | 30 |
| 10 | OLIGODEOXYRIBONUCLEOSIDE METHYLPHOSPHONATES | 25 | 52% | 1% | 34 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT | 54 | 34% | 5% | 128 |
| 2 | ANTISENSE RESEARCH AND DEVELOPMENT | 38 | 60% | 2% | 42 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Progress in antisense technology | 2004 | 286 | 125 | 66% |
| Antisense oligonucleotides: Basic concepts and mechanisms | 2002 | 288 | 111 | 59% |
| A review of issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides | 1999 | 269 | 72 | 65% |
| ANTISENSE OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS - IS THE BULLET REALLY MAGICAL | 1993 | 1223 | 122 | 52% |
| PHARMACOKINETICS OF ANTISENSE OLIGONUCLEOTIDES | 1995 | 197 | 11 | 100% |
| Nucleic-acid therapeutics: Basic principles and recent applications | 2002 | 304 | 127 | 35% |
| Antisense oligonucleotides: Promise and reality | 2001 | 177 | 74 | 61% |
| Antisense oligonucleotide pharmacokinetics and metabolism | 2009 | 58 | 59 | 59% |
| Antisense therapeutics | 1998 | 174 | 30 | 63% |
| Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides | 1999 | 147 | 84 | 69% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CHEM G 838 | 5 | 63% | 0.2% | 5 |
| 2 | CHIM THER EUT RADIOPHARM | 2 | 67% | 0.1% | 2 |
| 3 | GRP DRUG TARGETING DELIVERY POORLY STABLE CPDS | 2 | 67% | 0.1% | 2 |
| 4 | UCL 7541 | 2 | 67% | 0.1% | 2 |
| 5 | ASTON GENE BASED THER EUT | 1 | 100% | 0.1% | 2 |
| 6 | JIANGXI OAI GEMEINSAMES | 1 | 100% | 0.1% | 2 |
| 7 | STELLAR CHANCE S 513B | 1 | 100% | 0.1% | 2 |
| 8 | UCL 7340 | 1 | 50% | 0.1% | 2 |
| 9 | CARLSBAD | 1 | 20% | 0.2% | 5 |
| 10 | IFR PATHOL INFECT | 1 | 24% | 0.2% | 4 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000149784 | SYNTHET BIOORGAN CHEM//NUCLE ACID//NUCL ACID |
| 2 | 0.0000142549 | OLIGONUCLEOTIDE DERIVATIVES//NOVOSIBIRSK BIOORGAN CHEM//PHOTOAFFINITY MODIFICATION |
| 3 | 0.0000139099 | OLIGONUCLEOTIDE PEPTIDE CONJUGATE//PEPTIDE OLIGONUCLEOTIDE CONJUGATE//OLIGONUCLEOTIDE PEPTIDE CONJUGATES |
| 4 | 0.0000130955 | L DNA//HETEROCHIRAL DNA//UMR CNRS UMII 5625 |
| 5 | 0.0000127691 | EXON SKIPPING//DMD GENET THER Y GRP//MC LOCKWOOD MUSCULAR DYSTROPHY |
| 6 | 0.0000125999 | BORANOPHOSPHATE//PHOSPHONOFLUORIDATE//BORANOPHOSPHONATE |
| 7 | 0.0000086647 | TRIPLEX DNA//DNA TRIPLEX//TRIPLEX |
| 8 | 0.0000084192 | H PHOSPHONATES//OLIGONUCLEOTIDE SYNTHESIS//UNIVERSAL SOLID SUPPORT |
| 9 | 0.0000077384 | TRANSCRIPTION FACTOR DECOY//DECOY//DECOY OLIGODEOXYNUCLEOTIDE |
| 10 | 0.0000073439 | COLD INDUCED HYPERTENSION//ANTISENSE ELEMENTS//AT1 RECEPTOR ANTISENSE |